You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BIBW 2992

Showing 1 - 25 of 97
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Cancer Trial in Hamburg (BIBW 2992 (Afatinib))

Terminated
  • Refractory Cancer
  • BIBW 2992 (Afatinib)
  • Hamburg, Germany
    University Medical Center Hamburg-Eppendorf
Jun 29, 2022

NSCLC Trial in Goyang-si (BIBW 2992, simvastatin)

Completed
  • Non-small Cell Lung Cancer
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
Apr 4, 2022

Advanced Malignant Solid Tumor, Bile Duct Carcinoma, Recurrent Malignant Solid Tumor Trial in Indianapolis, Seattle (Afatinib

Completed
  • Advanced Malignant Solid Neoplasm
  • +6 more
  • Afatinib Dimaleate
  • +2 more
  • Indianapolis, Indiana
  • +1 more
Jun 3, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Afatinib

Active, not recruiting
  • Advanced Lymphoma
  • +5 more
  • Afatinib Dimaleate
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jun 28, 2022

Carcinoma, Squamous Cell of Head and Neck Trial in France (Afatinib)

Completed
  • Carcinoma, Squamous Cell of Head and Neck
  • Angers, France
  • +10 more
Feb 1, 2022

NSCLC Trial in Worldwide (Afatinib)

Completed
Has Results
  • NSCLC
  • Köln, Germany
  • +4 more
Aug 23, 2022

NSCLC Stage IV Trial in Taipei (therapeutic thoracic surgery, Afatinib)

Recruiting
  • NSCLC Stage IV
  • Taipei, Taiwan
  • +1 more
Mar 8, 2022

Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Sacramento (Afatinib Dimaleate,

Completed
  • Recurrent Non-Small Cell Lung Carcinoma
  • +3 more
  • Afatinib Dimaleate
  • Pembrolizumab
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Sep 29, 2021

Endometriosis, Endometriosis Ovary, Endometriosis Externa Trial in Basel (Linifanib, BIBW2992, Axitinib)

Withdrawn
  • Endometriosis
  • +3 more
  • Linifanib
  • +2 more
  • Basel, Вâlе, Switzerland
    BioGene Pharmaceutical Ltd.
Oct 24, 2021

Lung Cancer, NSCLC (NSCLC) Trial in Tampa (Dasatinib - 1A, Afatinib - 1A, Dasatinib - 1B)

Completed
Has Results
  • Lung Cancer
  • Non-small Cell Lung Cancer (NSCLC)
  • Dasatinib - 1A
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 24, 2020

Head and Neck Squamous Cell Carcinoma Trial in France (AFATINIB, Placebo of AFATINIB)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • Angers, France
  • +25 more
May 28, 2021

Distal Urethral Cancer, Proximal Urethral Cancer, Recurrent Bladder Cancer Trial in United States (afatinib dimaleate,

Recruiting
  • Distal Urethral Cancer
  • +8 more
  • afatinib dimaleate
  • laboratory biomarker analysis
  • Atlanta, Georgia
  • +5 more
Sep 24, 2021

Metastatic Disease Trial in Mainz (BIBW 2992)

Terminated
Has Results
  • Metastatic Disease
  • BIBW 2992
  • Mainz, Germany
    I. Medizinische Klinik und Poliklinik der Universitätsmedizin
Aug 26, 2019

HER2-positive Breast Cancer, Brain Metastases Trial in China (Afatinib, T-DM1)

Recruiting
  • HER2-positive Breast Cancer
  • Brain Metastases
  • Beijing, Beijing, China
  • +3 more
May 9, 2020

Glioblastoma Trial in United Kingdom (Temozolomide, Radiotherapy, BIBW2992)

Completed
Has Results
  • Glioblastoma
  • Cambridge, United Kingdom
  • +4 more
Feb 11, 2019

Tumors Trial in Bruxelles, Edegem, Gent (BI 6727 + BIBW 2992)

Completed
Has Results
  • Neoplasms
  • BI 6727 + BIBW 2992
  • Bruxelles, Belgium
  • +2 more
Aug 24, 2018

Non Small Cell Lung Cancer Trial in Tbilisi (Afatinib, Talcum powder)

Unknown status
  • Non Small Cell Lung Cancer
  • Tbilisi, Georgia
    Central Contact
Sep 8, 2019

Lung Cancer Trial in Houston (BIBW 2992)

Terminated
Has Results
  • Lung Cancer
  • BIBW 2992
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 8, 2019

NSCLC Trial in United Kingdom (Afatinib (BIBW 2992))

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Afatinib (BIBW 2992)
  • Bournemouth, United Kingdom
  • +14 more
Jan 11, 2019

Squamous Cell Carcinoma of Esophagus Trial in Seoul (BIBW2992)

Unknown status
  • Squamous Cell Carcinoma of Esophagus
  • Seoul, Korea, Republic of
    Severance hospital
Feb 7, 2019

Head and Neck Tumors Trial in Worldwide (Placebo, Afatinib)

Terminated
Has Results
  • Head and Neck Neoplasms
  • Beijing, China
  • +16 more
Oct 29, 2018

NSCLC, Adenocarcinoma Trial in China, Korea, Republic of, Thailand (Gemcitabine+Cisplatin, BIBW 2992)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Adenocarcinoma
  • Beijing, China
  • +35 more
Dec 13, 2018

NSCLC Trial in Guangzhou (inetetamab, Pytotinib)

Recruiting
  • Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Aug 16, 2021

NSCLC Trial in Worldwide (Afatinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Beijing, China
  • +32 more
Jun 27, 2019

Breast Tumors Trial in Worldwide (Vinorelbine 25 mg/m2 weekly, Afatinib 40mg once daily (OD), Paclitaxel 80 mg/m2 weekly)

Completed
Has Results
  • Breast Neoplasms
  • Vinorelbine 25 mg/m2 weekly
  • +2 more
  • Hong Kong, Hong Kong
  • +26 more
Mar 15, 2019